Skip to content

IONS IONIS PHARMACEUTICALS INC

Follow

Stock (common), issuer CIK 874015

Filings received so far for Q3 2026: 11 13F filers report a position in IONS shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Wedmont Private Capital6,400$277K0.01%-32313F-HRTimeline
Versant Capital Management, Inc2,000$89.3K0.01%+54013F-HRTimeline
GAMMA Investing LLC1,763$78.7K<0.01%-40513F-HRTimeline
Farther Finance Advisors, LLC732$32.7K<0.01%-37913F-HRTimeline
CoreCap Advisors, LLC370$16.5K<0.01%013F-HRTimeline
EASTERN BANK300$13.4K<0.01%013F-HRTimeline
Trust Co250$11.2K<0.01%013F-HRTimeline
MassMutual Private Wealth & Trust, FSB124$5.54K<0.01%+3413F-HRTimeline
CX Institutional46$2K<0.01%-15713F-HRTimeline
Planning Strategies Inc.12$536<0.01%+413F-HRTimeline
GILPIN WEALTH MANAGEMENT, LLC1$45<0.01%new13F-HRTimeline